Business context and reporting period
PennantPark Floating Rate Capital Ltd. is an externally managed business development company (BDC) and regulated investment company (RIC) that primarily lends to U.S. middle-market businesses. Its strategy focuses on floating-rate loans, especially first-lien secured debt. Although the request metadata says “2022 Q4,” this filing is the Form 10-K for the fiscal year ended September 30, 2023; figures below summarize that filing.
Key financial and operating metrics
- Investment income: $139.3 million in FY2023, up from $105.5 million in FY2022, primarily reflecting higher SOFR and a larger portfolio.
- Net investment income: $67.5 million, or $1.33 per share, compared with $48.6 million, or $1.18 per share.
- Net results: Net increase in net assets from operations was $39.3 million ($0.77 per share), versus $3.5 million ($0.08 per share) in FY2022. FY2023 included $16.2 million of realized investment losses and $12.6 million of net investment unrealized depreciation.
- Portfolio: Fair value was $1.067 billion, down from $1.164 billion. It comprised $906.2 million of first-lien debt, $0.1 million of second-lien debt, and $160.9 million of preferred and common equity. Debt investments were approximately 100% variable-rate; weighted-average debt yield was 12.6%, compared with 10.0% a year earlier.
- Credit performance: Three portfolio companies were on non-accrual, representing 0.9% of portfolio cost and 0.2% of fair value; the prior-year count was two, with 0.9% at cost and zero at fair value. The portfolio held investments in 131 companies, versus 125, and had $25.7 million of cumulative net unrealized depreciation.
- Liquidity and cash flow: Cash and cash equivalents were $100.6 million, versus $51.5 million. The cash flow statement reports $140.6 million provided by operating activities and $91.5 million used in financing activities; ending cash increased by $49.0 million. Unused capacity under the $386 million revolving facility was $376.6 million, subject to covenants and borrowing-base restrictions.
- Debt and leverage: Consolidated debt outstanding was $498.6 million, with a 5.6% weighted-average rate at year-end; annualized weighted-average borrowing cost was 6.3%, up from 4.5%. Debt included $9.4 million under the Credit Facility, $76.2 million of 2023 Notes, $185.0 million of 2026 Notes, and $228.0 million of 2031 asset-backed debt. Asset coverage was 230%, versus 178% in FY2022; leverage was reported at 76% of net assets.
- NAV and distributions: NAV per share was $11.13, down from $11.62. Distributions were $1.19 per share ($60.5 million), versus $1.14 per share ($46.7 million). The shares closed at $10.66, below year-end NAV.
Material changes versus FY2022
- Higher floating-rate income increased investment income and net investment income, while debt-related interest and expenses rose to $38.2 million from $29.8 million.
- The portfolio contracted in fair value and recorded net unrealized depreciation of $12.6 million during FY2023, compared with $24.5 million in FY2022. Realized investment losses increased to $16.2 million from $11.1 million.
- Credit Facility borrowings fell to $9.4 million from $168.8 million; unused facility capacity increased to $376.6 million from $197.2 million. The facility was upsized to $386 million in July 2023.
- The company issued 9.1 million shares through its ATM program during FY2023, raising $100.2 million net at an average $11.03 per share. The program’s maximum offering amount was increased to $250 million; $154.1 million remained available at year-end.
- A prior-period presentation error was corrected: FY2022 cash and “due to affiliates” were each increased by $3.6 million. The correction did not affect net assets, NAV per share, net investment income, or operating results.
Outlook, risks, contingencies, and unusual items
- The filing provides no specific earnings, yield, or distribution guidance. Management intends to continue monthly distributions, subject to board decisions, legally available assets, regulatory asset-coverage requirements, and income and liquidity.
- Management identifies credit deterioration, borrowers’ ability to service higher interest costs, inflation, market volatility, illiquid Level 3 valuations, funding access, leverage, refinancing, and compliance with debt covenants as key risks. The Credit Facility’s revolving period ends in August 2024 and it matures in August 2026.
- The 2023 Notes had $76.2 million outstanding at September 30, 2023; the filing describes a December 15, 2023 installment equal to 55% of original principal. The supplied filing text does not clearly state the subsequent repayment or refinancing outcome.
- Management and the auditor identified material weaknesses in controls over quarterly cash and investment reconciliations, interest income review, and non-accrual classification. Management said remediation was underway but could not estimate completion timing. The auditor gave an unqualified opinion on the financial statements but concluded internal control over financial reporting was not effective.
- The auditor highlighted Level 3 fair value measurements as a critical audit matter. Most investments require significant judgment and unobservable inputs; actual sale proceeds may differ materially from reported values. No material legal proceedings were reported.
Important facts for investors to verify
- Whether the December 2023 2023 Notes principal installment was paid, refinanced, or otherwise addressed after the reporting date.
- Current non-accrual status, watch-list exposures, borrower performance under higher rates, and any subsequent portfolio valuation changes.
- Progress in remediating the identified control weaknesses and whether the restated cash presentation or other errors recur.
- Actual availability of the revolving facility after applying borrowing-base, covenant, and regulatory restrictions, and the plan for its 2024 revolving-period end and 2026 maturity.
- Distribution coverage by cash net investment income and taxable income, including any return-of-capital implications.
- Share issuance under the expanded ATM program, including pricing relative to NAV and resulting dilution.